Document is current
Any future updates will be listed below
-
Authors
Peterson, Alan L.
Mintz, Jim
Moring, John C.
Straud, Casey L.
Young-McCaughan, Stacey
McGeary, Cindy A.
McGeary, Donald D.
Litz, Brett T.
Velligan, Dawn I.
Macdonald, Alexandra
Mata-Galan, Emma
Holliday, Stephen L.
Dillon, Kirsten H.
Roache, John D.
Bira, Lindsay M.
Nabity, Paul S.
Medellin, Elisa M.
Hale, Willie J.
Resick, Patricia A.
- License Information
-
More Information
Article History
Received: 3 June 2021
Accepted: 4 January 2022
First Online: 17 January 2022
Declarations
:
: This study was approved by the Institutional Review Boards at the University of Texas Health Science Center at San Antonio, Duke University, and the Boston VA. The U.S. Army Medical Research and Materiel Command (now the U.S. Army Medical Research and Development Command) Human Research Protection Office reviewed the regulatory determinations. Adverse events (AEs) were monitored during each participant contact using an AE monitoring program used in previous clinical trials [CitationRef removed]. All subjects provided written informed consent after receiving a complete description of the study. The study was performed in accordance with the guidelines outlined in the Declaration of Helsinki.
: Not applicable.
: The authors declare they have no competing interests.
